STOCK TITAN

Alto Ingredients, Inc. (NASDAQ: ALTO) swings to $11.4M Q2 profit

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Alto Ingredients reported much stronger results for the quarter ended June 30, 2026. Net sales were $245,698 thousand, up from $218,436 thousand a year earlier. Gross profit was $16.6 million, versus a gross loss in 2025, and Adjusted EBITDA was $23.7 million, both sharply higher year over year. Net income attributable to common stockholders was $11.4 million, or $0.15 per share, compared with a net loss of $11,312 thousand.

For the six months ended June 30, 2026, net sales were $470,378 thousand and net income attributable to common stockholders was $15,345 thousand, compared with a loss of $23,303 thousand in the prior-year period. Management noted this was the fourth consecutive quarter with positive gross profit, income from operations, net income and Adjusted EBITDA, supported by diversification across renewable fuels, specialty alcohols and essential ingredients and by earnings from Section 45Z tax credits. Transferable tax credits, net, contributed $5,112 thousand in Q2 and $9,012 thousand year to date. Cash and cash equivalents were $24.0 million at June 30, 2026, with borrowing availability of $106 million. The company also established a $50 million at-the-market equity program to provide additional financial flexibility for high-return organic projects.

Positive

  • Q2 2026 profitability: Net income attributable to common stockholders was $11.4 million (or $0.15 per share), compared with a net loss of $11,312 thousand in Q2 2025, and Adjusted EBITDA improved to $23.7 million from a small loss.
  • Balance sheet and liquidity: Cash and cash equivalents were $24.0 million at June 30, 2026, with borrowing availability of $106 million, and stockholders’ equity increased to 259,877 thousand from 245,241 thousand at year-end 2025.

Negative

  • None.

Filing Explained

The August 5 disclosure establishes a 50 million dollar share-selling capacity, but reports no current issuance or proceeds.

For existing common holders, this is a conditional financing capacity: if used, it could create dilution through new shares, but the filing does not report that this has occurred.

An at-the-market program lets the issuer sell new shares gradually into the open market at prevailing prices rather than in a single priced deal; management says any use will be evaluated against other capital sources and market conditions.

The Form 8-K furnishes the results release under Item 2.02 and states that the information is not filed for purposes of Section 18 of the Exchange Act.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net sales Q2 2026 $245,698 thousand Three months ended June 30, 2026; compared with $218,436 thousand in 2025
Net income attributable to common Q2 2026 $11.4 million Three months ended June 30, 2026; per share $0.15 basic and diluted
Adjusted EBITDA Q2 2026 $23.7 million Three months ended June 30, 2026; up from $(231) thousand in Q2 2025
Net sales six months 2026 $470,378 thousand Six months ended June 30, 2026; compared with $444,976 thousand in 2025
Net income attributable to common six months 2026 $15,345 thousand Six months ended June 30, 2026; compared with a net loss of $23,303 thousand in 2025
Cash and cash equivalents $24.0 million Balance at June 30, 2026; slightly above $23.4 million at December 31, 2025
Borrowing availability $106 million Availability at June 30, 2026, including $41 million under the operating line and $65 million under the term loan
ATM equity program size $50 million New at-the-market equity program established on August 5, 2026
Adjusted EBITDA financial
"The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Section 45Z tax credits financial
"increase our earnings from 45Z tax credits"
at-the-market equity program financial
"Today, we established a $50 million at-the-market equity program"
An at-the-market equity program lets a company sell newly issued shares directly into the open market at the current trading price through a broker, rather than in a single, prearranged block. It provides flexible, on-demand access to cash—like drawing small amounts from a credit line—but increases the number of shares outstanding, which can reduce existing shareholders’ ownership percentage and put downward pressure on the stock price, so investors monitor program size and pacing.
transferable tax credits financial
"Transferable tax credits, net, contributed $5,112 thousand in Q2"
Transferable tax credits are government-awarded reductions in future tax bills that the recipient can sell or transfer to another taxpayer instead of using them personally. Think of them like a sold gift card that converts a future tax benefit into cash today. For investors, they matter because they can improve a project’s cash flow and value, lower financing needs and risk, and make otherwise marginal deals financially attractive.
corn crush financial
"Board corn crush per gallons (1) was $0.33 in Q2 2026"
Essential ingredients return % financial
"Consolidated total return for essential ingredients return % was 51.6%"
Net sales (Q2 2026) $245,698 thousand up from $218,436 thousand in Q2 2025
Net income attributable to common (Q2 2026) $11.4 million compared with a net loss of $11,312 thousand in Q2 2025
Adjusted EBITDA (Q2 2026) $23.7 million improved from $(231) thousand in Q2 2025
Net income attributable to common (six months 2026) $15,345 thousand compared with a net loss of $23,303 thousand in the 2025 period

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What were Alto Ingredients’ (ALTO) Q2 2026 net sales and net income?

Alto Ingredients’ Q2 2026 net sales were $245,698 thousand, up from $218,436 thousand a year earlier. Net income attributable to common stockholders was $11.4 million, or $0.15 per share, versus a net loss of $11,312 thousand in Q2 2025.

How did Alto Ingredients’ (ALTO) Adjusted EBITDA change in Q2 2026?

Adjusted EBITDA in Q2 2026 was $23.7 million, compared with $(231) thousand in Q2 2025. The company stated that Q2 2026 Adjusted EBITDA improved by $23.9 million, marking the fourth consecutive quarter of positive Adjusted EBITDA.

What tax credits affected Alto Ingredients’ (ALTO) Q2 2026 results?

Alto Ingredients recognized $5,112 thousand of transferable tax credits, net, in Q2 2026 and $9,012 thousand year to date. Management linked these to Section 45Z tax credits, noting they contributed to earnings alongside operational improvements and diversification.

What is Alto Ingredients’ (ALTO) $50 million at-the-market equity program?

Management said it established a $50 million at-the-market equity program to add financial flexibility. Together with borrowing capacity and operating cash flow, this ATM is intended as a prudent, low-cost tool to fund attractive organic projects when conditions and shareholder interests align.

What was Alto Ingredients’ (ALTO) liquidity position at June 30, 2026?

At June 30, 2026, Alto Ingredients held $24.0 million of cash and cash equivalents and reported borrowing availability of $106 million. This included $41 million under its operating line of credit and $65 million under its term loan facility, supporting ongoing operations and investments.

How did Alto Ingredients’ (ALTO) volumes and pricing trend in Q2 2026?

Total alcohol gallons sold were 88.5 million in Q2 2026 versus 86.7 million a year earlier. The average sales price per gallon rose to $2.15 from $1.95, while total essential ingredients sold were 292.5 thousand tons and consolidated essential ingredients return increased to 51.6% from 45.2%.
false 0000778164 0000778164 2026-08-05 2026-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 5, 2026

 

ALTO INGREDIENTS, INC.
(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-21467   41-2170618
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1300 South Second Street
Pekin, Illinois
  61554
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (833) 710-2586

 

N/A

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   ALTO  

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On August 5, 2026, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and six months ended June 30, 2026. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Number   Description
99.1   Press Release dated August 5, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 5, 2026 ALTO INGREDIENTS, INC.
     
  By: /s/ AUSTE M. GRAHAM
    Auste M. Graham,
    Chief Legal Officer and Secretary

 

2

 

Exhibit 99.1

 

 

 

Alto Ingredients, Inc. Reports Second Quarter 2026 Results

 

Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million
Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million
Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million

 

Pekin, Ill., August 5, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended June 30, 2026.

 

“Alto’s second quarter results mark the fourth consecutive quarter of positive gross profit, income from operations, net income and adjusted EBITDA. We have maintained consistent profitability over this period even before the contribution of earnings from 45Z tax credits. These results demonstrate the benefits of our diversification strategy, which gives us the flexibility to shift production toward the most attractive end markets and capture premium-value opportunities,” said President and Chief Executive Officer Bryon McGregor.

 

“Having begun a strategic realignment three years ago, we now have a diversified product portfolio, a leaner cost structure and an operating model capable of generating positive adjusted EBITDA through commodity cycles while providing meaningful upside when market conditions are favorable,” added Mr. McGregor. “In addition, we have numerous initiatives in process and ahead of us to expand capacity, optimize CO2 production, improve efficiencies and increase our earnings from 45Z tax credits.”

 

Mr. McGregor concluded, “Our second quarter and latest 12-month financial results, combined with our ability to execute on high-return opportunities, reinforce our confidence in Alto’s ability to generate sustainable earnings and create long-term shareholder value.”

 

Rob Olander, Chief Financial Officer, added that, “Today, we established a $50 million at-the-market equity program. Alongside our available borrowing capacity and operating cash flow, the ATM program provides additional financial flexibility and a prudent, low-cost tool to effectively access equity capital. We see a number of attractive, high-return organic opportunities across our platform. Having the ATM program in place allows us to remain prepared to pursue those opportunities when expected returns, market conditions and shareholder interests align. Any use of the program would be disciplined, measured and evaluated against other sources of available capital.”

 

Financial Results for the Three Months Ended June 30, 2026 Compared to 2025

 

  Net sales were $245.7 million, compared to $218.4 million.

 

Cost of goods sold was $229.1 million, compared to $220.4 million.

 

Gross profit was $16.6 million, compared to a gross loss of $1.9 million.

 

1

 

 

 

Selling, general and administrative expenses were $8.0 million, compared to $6.2 million.

 

Interest expense was $2.0 million, compared to $2.8 million.

 

Net income attributable to common stockholders was $11.4 million, or $0.15 per diluted share, compared to a net loss of $11.3 million, or $0.15 per share.

 

Adjusted EBITDA was $23.7 million, compared to negative $0.2 million, an increase of $23.9 million.

 

Cash and cash equivalents at June 30, 2026 were $24.0 million, compared to $23.4 million at December 31, 2025. The company’s borrowing availability at June 30, 2026 was $106 million, including $41 million under the company’s operating line of credit and $65 million under its term loan facility.

 

Second Quarter 2026 Results Conference Call

 

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, August 5, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

 

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally. Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

 

Use of Non-GAAP Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles (“GAAP”) are useful measures of operations. The company defines Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company’s performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company’s results as reported under GAAP.

 

2

 

 

 

About Alto Ingredients, Inc.

 

Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of renewable fuels, essential ingredients and specialty alcohols. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations around expanding production capacity; profitability and executing on opportunities to grow earnings, including through improved utilization and reliability, optimization and capital projects, and monetizing additional Section 45Z tax credits; the use and benefits of its ATM program, including returns that Alto Ingredients may generate from using funds, if any, from the program to make capital investments; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others, adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; prevailing market prices and trading volumes of Alto Ingredients’ stock; Alto Ingredients’ ability, if desirable, to execute on its ATM program; Alto Ingredients’ ability to timely and within budget execute on its optimization and capital projects; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section 45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026.

 

Company IR and Media Contact:

 

Michael Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

 

IR Agency Contact:

 

Jody Burfening, Alliance Advisors Investor Relations, 212-838-3777, 

Investorrelations@altoingredients.com 

 

3

 

 

 

ALTO INGREDIENTS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share data)

  

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2026   2025   2026   2025 
                 
Net sales  $245,698   $218,436   $470,378   $444,976 
Cost of goods sold   229,062    220,373    444,523    448,720 
Gross profit (loss)   16,636    (1,937)   25,855    (3,744)
Selling, general and administrative expenses   8,017    6,171    14,716    13,361 
Income (loss) from operations   8,619    (8,108)   11,139    (17,105)
Interest expense, net   (1,960)   (2,811)   (4,158)   (5,540)
Transferable tax credits, net   5,112        9,012     
Other expense, net   (70)   (78)   (21)   (31)
Income (loss) before provision for income taxes   11,701    (10,997)   15,972    (22,676)
Provision for income taxes                
Net income (loss)  $11,701   $(10,997)  $15,972   $(22,676)
Preferred stock dividends  $(315)  $(315)  $(627)  $(627)
Net income (loss) attributable to common stockholders  $11,386   $(11,312)  $15,345   $(23,303)
Net income (loss) per share, basic  $0.15   $(0.15)  $0.20   $(0.31)
Net income (loss) per share, diluted  $0.15   $(0.15)  $0.20   $(0.31)
Weighted-average shares outstanding, basic   75,588    74,611    75,191    74,232 
Weighted-average shares outstanding, diluted   77,071    74,611    76,609    74,232 

 

4

  

 

 

ALTO INGREDIENTS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

  

ASSETS  June 30,
2026
   December 31,
2025
 
Current Assets:        
Cash and cash equivalents  $23,962   $23,415 
Restricted cash       2,258 
Accounts receivable, net   67,889    55,069 
Inventories   51,609    61,676 
Transferable tax credits, net   8,265    7,500 
Derivative instruments   4,173    525 
Other current assets   4,926    5,474 
Total current assets   160,824    155,917 
Property and equipment, net   197,479    198,501 
Other Assets:          
Right of use operating lease assets, net   21,492    16,931 
Intangible assets, net   7,264    7,574 
Other assets   10,011    9,863 
Total other assets   38,767    34,368 
Total Assets  $397,070   $388,786 

 

5

 

 

 

ALTO INGREDIENTS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

 

  June 30,
2026
   December 31,
2025
 
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current Liabilities:        
Accounts payable  $24,219   $14,509 
Accrued liabilities   16,424    16,691 
Current portion – long-term debt       16,600 
Current portion – operating leases   4,916    4,958 
Derivative instruments   277    1,067 
Other current liabilities   4,561    5,246 
Total current liabilities   50,397    59,071 
           
Long-term debt, net   60,469    63,027 
Operating leases, net of current portion   17,553    13,012 
Other liabilities   8,774    8,435 
Total Liabilities   137,193    143,545 
           
Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: no shares issued and outstanding as of June 30, 2026 and December 31, 2025 Series B: 927 shares issued and outstanding as of June 30, 2026 and December 31, 2025   1    1 
Common stock, $0.001 par value; 300,000 shares authorized; 77,576 and 77,307 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively   78    77 
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of June 30, 2026 and December 31, 2025        
Additional paid-in capital   1,051,085    1,051,795 
Accumulated other comprehensive income   5,461    5,461 
Accumulated deficit   (796,748)   (812,093)
Total Stockholders’ Equity   259,877    245,241 
Total Liabilities and Stockholders’ Equity  $397,070   $388,786 

 

6

 

 

 

Reconciliation of Adjusted EBITDA to Net Income (Loss)

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
(in thousands) (unaudited)  2026   2025   2026   2025 
Net income (loss)  $11,701   $(10,997)  $15,972   $(22,676)
Adjustments:                    
Interest expense   1,960    2,811    4,158    5,540 
Interest income   (87)   (67)   (165)   (150)
Unrealized derivative losses (gains)   3,634    2,117    (4,439)   483 
Acquisition-related income       (460)       (460)
Depreciation and amortization expense   6,452    6,365    12,819    12,631 
Total adjustments   11,959    10,766    12,373    18,044 
Adjusted EBITDA  $23,660   $(231)  $28,345   $(4,632)

  

7

 

 

 

Segment Financials (in thousands) (unaudited)

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2026   2025   2026   2025 
Net Sales                
Pekin Campus production:                
Alcohol sales  $114,370   $94,155   $222,321   $201,390 
Essential ingredient sales   45,071    39,565    89,064    84,183 
Intersegment sales   229    183    492    481 
Total Pekin Campus sales   159,670    133,903    311,877    286,054 
                     
Marketing and distribution:                    
Alcohol sales, gross  $54,612   $58,106   $101,889   $107,101 
Alcohol sales, net   60    80    109    142 
Intersegment sales   2,512    2,334    4,962    4,840 
Total marketing and distribution sales   57,184    60,520    106,960    112,083 
                     
Western production:                    
Alcohol sales  $20,798   $16,604   $37,479   $32,798 
Essential ingredient sales   8,843    8,250    16,123    16,058 
Intersegment sales   449    505    848    769 
Total Western production sales   30,090    25,359    54,450    49,625 
                     
Corporate and other   1,944    1,676    3,393    3,304 
Intersegment eliminations   (3,190)   (3,022)   (6,302)   (6,090)
Net sales as reported  $245,698   $218,436   $470,378   $444,976 
Cost of goods sold:                    
Pekin Campus production  $148,148   $139,748   $292,918   $294,974 
Marketing and distribution   53,404    56,518    99,442    104,167 
Western production   27,955    23,501    52,707    49,024 
Corporate and other   1,010    1,705    2,046    3,386 
Intersegment eliminations   (1,455)   (1,099)   (2,590)   (2,831)
Cost of goods sold as reported  $229,062   $220,373   $444,523   $448,720 
Gross profit (loss):                    
Pekin Campus production  $11,522   $(5,845)  $18,959   $(8,920)
Marketing and distribution   3,780    4,002    7,518    7,916 
Western production   2,135    1,858    1,743    601 
Corporate and other   934    (29)   1,347    (82)
Intersegment eliminations   (1,735)   (1,923)   (3,712)   (3,259)
Gross profit (loss) as reported  $16,636   $(1,937)  $25,855   $(3,744)

  

8

 

 

 

Sales and Operating Metrics (unaudited)

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2026   2025   2026   2025 
Alcohol Sales (gallons in millions)                
Pekin Campus renewable fuel gallons sold   31.6    28.8    62.8    61.4 
Western production renewable fuel gallons sold   9.4    8.3    17.6    16.6 
Third-party renewable fuel gallons sold   24.0    29.7    47.5    54.1 
Total renewable fuel gallons sold   65.0    66.8    127.9    132.1 
Specialty alcohol gallons sold   23.5    19.9    46.5    44.2 
Total gallons sold   88.5    86.7    174.4    176.3 
                     
Sales Price per Gallon                    
Pekin Campus production  $2.09   $1.95   $2.05   $1.92 
Western production  $2.20   $2.00   $2.13   $1.98 
Marketing and distribution  $2.27   $1.96   $2.14   $1.98 
Average sales price per gallon  $2.15   $1.95   $2.08   $1.94 
                     
Alcohol Production (gallons in millions)                    
Pekin Campus production   51.8    50.9    103.0    105.2 
Western production   9.0    8.3    16.9    16.6 
Total production gallons   60.8    59.2    119.9    121.8 
                     
Corn Cost per Bushel                    
Pekin Campus production  $4.58   $4.86   $4.51   $4.75 
Western production  $5.59   $5.71   $5.57   $5.83 
Average cost per bushel  $4.73   $4.98   $4.65   $4.89 

 

9

 

 

 

Sales and Operating Metrics (unaudited)

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2026     2025     2026     2025  
Average Market Metrics                        
PLATTS Ethanol price per gallon   $ 1.92     $ 1.72     $ 1.82     $ 1.72  
CME Corn cost per bushel   $ 4.44     $ 4.51     $ 4.41     $ 4.62  
Board corn crush per gallons (1)   $ 0.33     $ 0.11     $ 0.25     $ 0.07  
                                 
Essential Ingredients Sold (thousand tons)                                
Pekin Campus production:                                
Distillers grains     68.2       70.2       148.6       160.9  
CO2     45.2       45.1       88.5       90.4  
Corn wet feed     26.3       28.7       56.2       63.2  
Corn dry feed     24.7       21.4       45.7       45.2  
Corn oil and germ     19.1       18.9       37.2       38.5  
Syrup and other     11.9       11.7       21.1       19.9  
Corn meal     8.2       8.3       17.7       17.7  
Yeast     5.9       5.7       12.0       12.1  
Total Pekin Campus essential ingredients sold     209.5       210.0       427.0       447.9  
                                 
Western production:                                
Distillers grains     67.0       61.8       127.1       119.9  
CO2     14.5       14.4       27.3       27.0  
Corn oil     0.9       1.0       1.7       2.4  
Syrup and other     0.6       1.2       1.4       2.0  
Total Western production essential ingredients sold     83.0       78.4       157.5       151.3  
                                 
Total Essential Ingredients Sold     292.5       288.4       584.5       599.2  
                                 
Essential ingredients return % (2)                                
Pekin Campus return     51.7 %     44.2 %     52.8 %     46.1 %
Western production return     51.4 %     50.8 %     50.7 %     49.9 %
Consolidated total return     51.6 %     45.2 %     52.5 %     46.7 %

  

 

(1)Assumes corn conversion of 2.80 gallons of alcohol per bushel of corn.
(2)Essential ingredients revenues as a percentage of total corn costs consumed.

 

####

 

10

 

Filing Exhibits & Attachments

4 documents